Nucleic acid nanomedicines in Phase II/III clinical trials: translation of nucleic acid therapies for reprogramming cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nucleic acid nanomedicines in Phase II/III clinical trials: translation of nucleic acid therapies for reprogramming cells
Authors
Keywords
-
Journal
Nanomedicine
Volume 13, Issue 16, Pages 2083-2098
Publisher
Future Medicine Ltd
Online
2018-09-11
DOI
10.2217/nnm-2018-0122
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy
- (2018) Changmai Chen et al. MEDICINAL RESEARCH REVIEWS
- Advances in Non-Viral DNA Vectors for Gene Therapy
- (2017) Cinnamon Hardee et al. Genes
- Liver immunology and its role in inflammation and homeostasis
- (2016) Mark W Robinson et al. Cellular & Molecular Immunology
- Evaluation of expansile nanoparticle tumor localization and efficacy in a cancer stem cell-derived model of pancreatic peritoneal carcinomatosis
- (2016) Victoria LM Herrera et al. Nanomedicine
- The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery
- (2016) Claudia Corbo et al. Nanomedicine
- Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials
- (2016) Joseph M. Caster et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Molecular mechanisms of Ebola virus pathogenesis: focus on cell death
- (2015) L Falasca et al. CELL DEATH AND DIFFERENTIATION
- Nucleic Acids Delivery Systems: A Challenge for Pharmaceutical Technologists
- (2015) Ana Silva et al. CURRENT DRUG METABOLISM
- Going beyond the liver: Progress and challenges of targeted delivery of siRNA therapeutics
- (2015) Cornelia Lorenzer et al. JOURNAL OF CONTROLLED RELEASE
- Synthetic Nucleic Acid Delivery Systems: Present and Perspectives
- (2015) Bogdan Draghici et al. JOURNAL OF MEDICINAL CHEMISTRY
- Clinical experiences with systemically administered siRNA-based therapeutics in cancer
- (2015) Jonathan E. Zuckerman et al. NATURE REVIEWS DRUG DISCOVERY
- Knocking down disease: a progress report on siRNA therapeutics
- (2015) Anders Wittrup et al. NATURE REVIEWS GENETICS
- Current concepts in the diagnosis and management of cytokine release syndrome
- (2014) D. W. Lee et al. BLOOD
- Non-viral vectors for gene-based therapy
- (2014) Hao Yin et al. NATURE REVIEWS GENETICS
- Synthesis of IL-6 by Hepatocytes Is a Normal Response to Common Hepatic Stimuli
- (2014) Callie A. Norris et al. PLoS One
- Delivery materials for siRNA therapeutics
- (2013) Rosemary Kanasty et al. NATURE MATERIALS
- Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery
- (2012) D. N. Nguyen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ebolavirus Proteins Suppress the Effects of Small Interfering RNA by Direct Interaction with the Mammalian RNA Interference Pathway
- (2011) G. Fabozzi et al. JOURNAL OF VIROLOGY
- Breaking down the barriers: siRNA delivery and endosome escape
- (2010) M. Dominska et al. JOURNAL OF CELL SCIENCE
- Strategies in the design of nanoparticles for therapeutic applications
- (2010) Robby A. Petros et al. NATURE REVIEWS DRUG DISCOVERY
- Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application
- (2009) Aimee L. Jackson et al. NATURE REVIEWS DRUG DISCOVERY
- Innate immune recognition of nucleic acids
- (2008) Tsan Xiao IMMUNOLOGIC RESEARCH
- The evolution of RNAi as a defence against viruses and transposable elements
- (2008) D. J Obbard et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search